Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 4, Pages e0108247
Publisher
Public Library of Science (PLoS)
Online
2015-04-14
DOI
10.1371/journal.pone.0108247
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II trial of temsirolimus alone and in combination with irinotecan forKRASmutant metastatic colorectal cancer: Outcome and results ofKRASmutational analysis in plasma
- (2013) Karen-Lise G. Spindler et al. ACTA ONCOLOGICA
- The correlation between cell-free DNA and tumour burden was estimated by PET/CT in patients with advanced NSCLC
- (2013) A D Nygaard et al. BRITISH JOURNAL OF CANCER
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients
- (2012) L. Benesova et al. ANALYTICAL BIOCHEMISTRY
- Alu-based cell-free DNA: A potential complementary biomarker for diagnosis of colorectal cancer
- (2012) Jing Qi et al. CLINICAL BIOCHEMISTRY
- Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
- (2012) K.-L. G. Spindler et al. CLINICAL CANCER RESEARCH
- Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers
- (2012) Geraldine Perkins et al. PLoS One
- Circulating Cell-Free DNA: A Promising Marker of Pathologic Tumor Response in Rectal Cancer Patients Receiving Preoperative Chemoradiotherapy
- (2011) Marco Agostini et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer
- (2011) Leticia De Mattos-Arruda et al. Future Oncology
- Improved Classification of Epithelial Ovarian Cancer
- (2011) Karina Dahl Steffensen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Real-time polymerase chain reaction quantification of free DNA in serum of patients with polyps and colorectal cancers
- (2010) Elisa Danese et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: A meta-analysis of 22 studies
- (2010) Li-Xin Qiu et al. EUROPEAN JOURNAL OF CANCER
- The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer
- (2009) K. -L. Garm Spindler et al. ANNALS OF ONCOLOGY
- Detection of Mutated K-rasDNA in Urine, Plasma, and Serum of Patients with Colorectal Carcinoma or Adenomatous Polyps
- (2009) Ying-Hsiu Su et al. Annals of the New York Academy of Sciences
- Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?
- (2009) Maniesh van der Vaart et al. CLINICAL BIOCHEMISTRY
- Detection of KRAS Oncogene in Peripheral Blood as a Predictor of the Response to Cetuximab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer
- (2009) L.-C. Yen et al. CLINICAL CANCER RESEARCH
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now